OQS
TCRT icon

Occudo Quantitative Strategies’s Alaunos Therapeutics TCRT Stock Holding History

Occudo Quantitative Strategies’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-351
Closed -$91K – 1354
2022
Q3 		$91K Buy
+351
New +$102K 0.01% 1045
2021
Q1 		– Sell
-875
Closed -$331K – 918
2020
Q4 		$331K Buy
+875
New +$348K 0.1% 381

Other funds holding TCRT

DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Addison Capital Conshohocken, Pennsylvania $562M AUM 18.57% 1-Year Est. Return
SGCA
Steel Grove Capital Advisors Memphis, Tennessee $949M AUM 23.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Occudo Quantitative Strategies's TCRT Position: Q4 2022 in Review

Occudo Quantitative Strategies sold out of Alaunos Therapeutics (TCRT) in Q4 2022, closing a stake of 351 shares — an estimated $91K sold.

Occudo Quantitative Strategies first reported a position in TCRT in Q4 2020 and held it in 2 quarters. The position peaked at $331K in Q4 2020. 122 funds tracked by Wall St. Rank hold TCRT as of Q4 2022.

  • Occudo Quantitative Strategies reported no remaining Alaunos Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 351 Alaunos Therapeutics shares in Q4 2022, an estimated $91K.
  • Occudo Quantitative Strategies first reported a position in Alaunos Therapeutics in Q4 2020 and held it in 2 quarters.
  • Occudo Quantitative Strategies's Alaunos Therapeutics position peaked at $331K in Q4 2020.
  • 122 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q4 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.